Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

"The older, the wiser" in prostate cancer treatment choices?

Repetto L, Abbatecola AM, Paolisso G.

Ann Intern Med. 2013 May 21;158(10):772-3. doi: 10.7326/0003-4819-158-10-201305210-00013. No abstract available.

PMID:
23689767
2.

Prostate-specific antigen screening for prostate cancer in older men in the United States of America.

Black A, Berg CD.

Gerontology. 2012;58(4):331-6. doi: 10.1159/000334242. Epub 2012 Feb 16.

3.

Screening for prostate cancer remains controversial.

Stark JR, Mucci L, Rothman KJ, Adami HO.

BMJ. 2009 Sep 24;339:b3601. doi: 10.1136/bmj.b3601. No abstract available.

PMID:
19778971
4.

Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.

Aus G.

Eur Urol. 2009 Jun;55(6):1331. doi: 10.1016/j.eururo.2009.02.030. Epub 2009 Mar 6. No abstract available.

PMID:
19286303
5.

Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Belpomme D, Irigaray P.

J Natl Cancer Inst. 2010 Apr 7;102(7):506-7. doi: 10.1093/jnci/djq045. Epub 2010 Feb 26. No abstract available.

PMID:
20190186
6.

Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?

Barry MJ, Mulley AJ Jr.

J Natl Cancer Inst. 2009 Mar 18;101(6):362-3. doi: 10.1093/jnci/djp028. Epub 2009 Mar 10. No abstract available.

PMID:
19276451
7.

PSA at 60 may predict risk of death from prostate cancer.

Rees J.

Practitioner. 2010 Oct;254(1733):5. No abstract available.

PMID:
21141246
8.

Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?

Carroll PR, Whitson JM, Cooperberg MR.

J Clin Oncol. 2011 Feb 1;29(4):345-7. doi: 10.1200/JCO.2010.32.5308. Epub 2010 Dec 28. No abstract available.

9.

[Detection of prostate cancer: yes or no?].

Van Cangh PJ.

Bull Mem Acad R Med Belg. 2006;161(3-4):159-69. Review. French. No abstract available.

PMID:
17172224
10.

Screening for prostate cancer: an updated review.

Marta GN, Hanna SA, Fernandes da Silva JL, Carvalho Hde A.

Expert Rev Anticancer Ther. 2013 Jan;13(1):101-8. doi: 10.1586/era.12.154. Review.

PMID:
23259431
11.

Screening for prostate cancer: prostate-specific antigen testing is not effective.

Hitzeman N, Molina M.

Am Fam Physician. 2011 Apr 1;83(7):802-4. No abstract available.

12.

Detecting and treating prostate cancer: a surgeon's perspective.

Buchan NC.

N Z Med J. 2012 Apr 20;125(1353):6-8. No abstract available.

PMID:
22522266
13.

Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.

[No authors listed]

Ann Intern Med. 2013 May 21;158(10):I-28. doi: 10.7326/0003-4819-158-10-201305210-00634. No abstract available.

PMID:
23567761
14.

[PSA doubling times of prostate carcinoma managed with watchful observation alone].

Dunst J.

Strahlenther Onkol. 2001 Dec;177(12):684-5. German. No abstract available.

PMID:
11789411
15.

[The Campaign Program for Prostate Integrated Research].

Cussenot O.

Bull Cancer. 2010 Dec;97(12):1497-8. French. No abstract available.

16.

Prostate cancer screening; is this a teachable moment?

Brawley OW.

J Natl Cancer Inst. 2009 Oct 7;101(19):1295-7. doi: 10.1093/jnci/djp310. Epub 2009 Aug 31. No abstract available.

PMID:
19720970
17.

Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.

Hattangadi JA, Chen MH, D'Amico AV.

BJU Int. 2012 Dec;110(11):1636-41. doi: 10.1111/j.1464-410X.2012.11354.x. Epub 2012 Jul 3.

18.

Relevant patient and tumor considerations for early prostate cancer treatment.

Leak B, Wei JT, Gabel M, Peabody JO, Menon M, Demers R, Tewari A.

Semin Urol Oncol. 2002 Feb;20(1):39-44. Review.

PMID:
11828356
19.

Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma.

Thompson IM, Ankerst DP, Tangen CM.

J Natl Cancer Inst. 2010 Sep 8;102(17):1299-301. doi: 10.1093/jnci/djq313. Epub 2010 Aug 19. No abstract available.

20.

Balancing the harms and benefits of early detection of prostate cancer.

van Leeuwen PJ, Connolly D, Tammela TL, Auvinen A, Kranse R, Roobol MJ, Schroder FH, Gavin A.

Cancer. 2010 Oct 15;116(20):4857-65. doi: 10.1002/cncr.25474.

Supplemental Content

Support Center